Background and Objectives Buprenorphine's high‐binding affinity as a partial µ‐opioid
agonist displaces preexisting full agonists causing precipitated withdrawal, which requires …

Background The past two decades have witnessed an epidemic of opioid use disorder
(OUD) in the USA, resulting in catastrophic loss of life secondary to opioid overdoses …

Abstract Background Conducted in the Dayton Metropolitan area of Southwestern Ohio, this
qualitative study explores the self-treatment practices of people who use illicit opioids …

With the aging population, an increasing number of older adults (> 65 years) will be affected
by problematic opioid use and opioid use disorder (OUD), with both illicit and prescription …

Opioid use disorder (OUD) is increasingly recognized as a chronic, relapsing brain disease
whose treatment should be integrated into primary care settings alongside other chronic …

Background and Objectives Buprenorphine/naloxone has been shown to be effective in the
treatment of opioid use disorder. Due to its pharmacological properties, induction can be …

Buprenorphine possesses many unique attributes that make it a practical agent for adults
and adolescents with opioid use disorder (OUD) and/or acute or chronic pain. Sublingual …

Background and Objectives Individuals exposed to fentanyl are at risk of precipitated
withdrawal using typical buprenorphine/naloxone induction procedures. Methods This case …

Low dose buprenorphine initiation, is an alternative method of initiating buprenorphine in
which the starting dose is very low and gradually increased to therapeutic levels over a …

Study Objective Buprenorphine, a partial μ‐opioid agonist, is an effective treatment for
opioid use disorder that conventionally requires symptoms of withdrawal before initiation to …